RenovoRx CFO buys shares and warrants

RenovoRx, Inc. Chief Financial Officer Mark Voll, through the Voll Family Trust, reported buying both common stock and warrants in a private placement.

Rhea-AI Filing Summary

RenovoRx, Inc. Chief Financial Officer Mark Voll, through the Voll Family Trust, reported buying both common stock and warrants in a private placement. The trust acquired 97,200 shares of common stock and 48,600 warrants, for an aggregate purchase price of $100,000.

The warrants are exercisable immediately at $1.9326 per share of underlying common stock and will expire on the earlier of March 30, 2029 or 30 days after RenovoRx reports at least $1.5 million in product sales revenue for any calendar quarter.

Insider Trade Summary

Net Buyer: 145,800 shares

Net Buy 2 txns

Insider VOLL MARK

Role Chief Financial Officer

Bought 145,800 shs ($0.00)

Type	Security	Shares	Price	Value
Purchase	Warrants	48,600	$0.00	$0.00
Purchase	Common Stock	97,200	$0.00	$0.00

Holdings After Transaction: Warrants — 48,600 contracts (Indirect, Voll Family Trust DTD 6/23/2010 Mark Voll TTEE); Common Stock — 97,200 shares (Indirect, Voll Family Trust DTD 6/23/2010 Mark Voll TTEE)

Footnotes (2)

1. F1. The securities were purchased in a private placement on March 20, 2026 for an aggregate of $100,000.
2. F2. The warrants are exercisable immediately upon issuance and expire on the earlier of (i) March 30, 2029 or (ii) 30 days following the date the Issuer reports at least $1.5 million in product sales revenue (excluding licensing fees, upfront milestones and grants, but including royalty revenue from product sales) for any calendar quarter in a quarterly or annual report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did RenovoRx (RNXT) report for CFO Mark Voll?

RenovoRx reported that CFO Mark Voll, via the Voll Family Trust, bought warrants and common stock. The trust acquired 48,600 warrants and 97,200 common shares in a private placement, reflecting an indirect increase in his economic exposure to RenovoRx.

How many RenovoRx (RNXT) shares and warrants were purchased in this Form 4?

The Voll Family Trust bought 97,200 common shares and 48,600 warrants of RenovoRx. These purchases were reported as open-market or private-transaction buys, increasing the trust’s indirect holdings to 97,200 common shares and 48,600 warrants following the transactions.

What was the total dollar amount of the RenovoRx (RNXT) insider purchase?

The securities were purchased for an aggregate of $100,000. This total covers both the common stock and the warrants acquired in the private placement completed on March 20, 2026, as disclosed in the filing footnotes.

What are the exercise terms of the RenovoRx (RNXT) warrants bought by the Voll Family Trust?

The warrants are exercisable immediately at an exercise price of $1.9326 per share. They expire on March 30, 2029, or 30 days after RenovoRx reports at least $1.5 million in product sales revenue for any calendar quarter.

How are the RenovoRx (RNXT) securities owned by CFO Mark Voll held?

The reported common stock and warrants are held indirectly through the Voll Family Trust. The filing lists ownership as indirect, with the nature of ownership described as “Voll Family Trust DTD 6/23/2010 Mark Voll TTEE” for both securities.

Does the RenovoRx (RNXT) Form 4 show buying or selling by the CFO’s trust?

The Form 4 shows net buying activity by the Voll Family Trust. Two purchase transactions were reported, with a combined 145,800 securities across common stock and warrants, and no sales or dispositions recorded in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/24/2026 - 09:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

VOLL MARK

(Last) (First) (Middle)

C/O RENOVORX, INC.

2570 W EL CAMINO REAL, SUITE 320

(Street)

MOUNTAIN VIEW CALIFORNIA 94040

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RenovoRx, Inc. [ RNXT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/20/2026	03/20/2026	P		97,200	A	(1)	97,200	I	Voll Family Trust DTD 6/23/2010 Mark Voll TTEE

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrants	$1.9326	03/20/2026	03/20/2026	P		48,600		(2)	(2)	Common Stock	48,600	(1)	48,600	I	Voll Family Trust DTD 6/23/2010 Mark Voll TTEE

Explanation of Responses:

1. The securities were purchased in a private placement on March 20, 2026 for an aggregate of $100,000.

2. The warrants are exercisable immediately upon issuance and expire on the earlier of (i) March 30, 2029 or (ii) 30 days following the date the Issuer reports at least $1.5 million in product sales revenue (excluding licensing fees, upfront milestones and grants, but including royalty revenue from product sales) for any calendar quarter in a quarterly or annual report.

	/s/ Mark Voll	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)